Global Polyurethane IV Cannula Market Strategic Research Report

Scope of the Report

The global Polyurethane IV Cannula market size is predicted to grow from US$ 1,568 million in 2025 to US$ 2,345 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.

Polyurethane IV Cannula refers to a medical device made of flexible polyurethane material, designed for intravenous access and long-term venous infusion. It consists of a soft catheter and a sharp introducer needle, enabling safe puncture into peripheral veins. The polyurethane material provides high biocompatibility, superior flexibility, and reduced risk of phlebitis or thrombosis compared to traditional PVC devices. These cannulas are manufactured in various gauges and lengths to suit different patient needs, ensuring precise fluid administration and medication delivery.

Polyurethane IV cannulas are widely used in hospitals, outpatient clinics, home care, and nursing facilities for fluid therapy, drug administration, blood transfusion, and parenteral nutrition. Advanced designs often include safety mechanisms to prevent needle-stick injuries and closed systems to minimize contamination risk. Their combination of comfort, safety, and reliability has made polyurethane IV cannulas the preferred choice for clinical intravenous procedures, particularly in high-risk or long-term infusion scenarios.

In 2025, global Polyurethane IV Cannula production reached approximately 594 million units, with an average market price of around US$2.7 per unit.

The global Polyurethane IV Cannula market has grown steadily due to increasing adoption of high-quality intravenous devices, growing awareness of patient safety, and rising demand for long-term infusion therapies in hospitals, outpatient clinics, and home care settings. Polyurethane IV cannulas are preferred over traditional PVC products for their superior flexibility, biocompatibility, and reduced risk of phlebitis and thrombosis. Safety features such as needle-stick prevention mechanisms and closed systems further support adoption in clinical environments.

Several factors are driving market expansion. The growth of healthcare infrastructure, aging populations, and increasing prevalence of chronic diseases are boosting demand for reliable venous access devices. Hospitals and clinics are replacing conventional PVC catheters with polyurethane variants, particularly in high-end wards, intensive care units, and surgical settings. Technological advancements in catheter design, safety systems, and infection prevention are also enhancing adoption.

Regionally, North America and Europe are mature markets with high adoption rates of polyurethane IV cannulas in hospitals and outpatient care. Asia-Pacific is the fastest-growing region due to expanding healthcare infrastructure, increased hospital bed capacity, and heightened awareness of infection control and patient comfort. Emerging markets in Latin America, the Middle East, and Africa are gradually increasing adoption as healthcare access and quality improve.

Despite favorable growth prospects, the market faces challenges such as higher unit costs compared to PVC devices, regulatory compliance requirements, and the need for skilled healthcare personnel for proper insertion and maintenance. Suppliers continue to invest in product innovation, cost optimization, and distribution expansion to increase market penetration. Future trends are expected to focus on enhanced safety features, eco-friendly materials, and integration with smart infusion systems to optimize patient care and operational efficiency.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Polyurethane IV Cannula market?

What factors are driving Polyurethane IV Cannula market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Polyurethane IV Cannula market opportunities vary by end market size?

How does Polyurethane IV Cannula break out by Type, by Application?

This report presents a comprehensive overview of the global Polyurethane IV Cannula market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Single-use Polyurethane Cannula
• Over-the-Needle Polyurethane Cannula
• Through-the-Needle Polyurethane Cannula

Segment by Application

• Hospital
• Clinical
• Home Care
• Others

Segment by Application

• Peripheral IV Cannula
• Central Venous Catheter

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Polyurethane IV Cannula market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Peripheral IV Cannula, Central Venous Catheter evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact